Listar MD - Artículos por autor "Lopez-Brea, Marta"
Mostrando ítems 1-2 de 2
-
Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
Aparicio, Jorge; Maroto, Pablo; García del Muro, Xavier; Sánchez-Muñoz, Alfonso
; Guma, Josep; Margelí, Mireia; Sáenz, Alberto; Sagastibelza, Naiara; Castellano, Daniel; Arranz-Arija, José Ángel; Hervás, David; Bastús, Romá; Fernández-Aramburo, Antonio; Sastre, Javier; Terrasa, Josefa; Lopez-Brea, Marta; Dorca, Joan; Almenar, Daniel; Carles, J.; Hernández, Álvaro; Germá-Lluch, José Ramón[et al.] (Elsevier, 2014-09-10)
Background: We aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the long-term patterns of recurrence in both groups. Patients ... -
Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study
Aparicio, Jorge; Maroto, Pablo; García del Muro, Xavier; Guma, Josep; Sánchez-Muñoz, Alfonso; Margelí, Mireia; Domenech, Montserrat; Bastús, Romá; Fernández, Antonio; Lopez-Brea, Marta; Terrassa, Josefa; Meana, Andrés; Martínez del Prado, Purificación; Sastre, Javier; Satrustegui, Juan J.; Girones, Regina; Robert, Lidia; Germa, José R.[et al.] (Editorial Roster. ASCO publications, 2011-10)
Purpose To confirm the efficacy of a risk-adapted treatment approach for patients with clinical stage I seminoma. The aim was to reduce both the risk of relapse and the proportion of patients receiving adjuvant chemotherapy ...